Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2052.67 (Glytoucan)

Id:1fa2ef7e-d950-5bd1-841f-46f5ecc8f433

Glytoucan:G22525FU

Results found

Linked to

	Label	Description
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G41191PN-GLYCOSEQ00181789 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000108 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G31124JV-GLYCOSEQ00105632 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G79961MR-GLYCOSEQ00074041 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G80487YW-GLYCOSEQ00139172 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000084 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G41191PN-GLYCOSEQ00181790 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G46511PG-GLYCOSEQ00139359 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2052.67 has canonical residue n-glycan a-d-neupnac 16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G41191PN-GLYCOSEQ00181789 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000108 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G31124JV-GLYCOSEQ00105632 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G79961MR-GLYCOSEQ00074041 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G80487YW-GLYCOSEQ00139172 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000084 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G41191PN-GLYCOSEQ00181790 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has glycosequence GLYGEN.GLYCOSEQUENCE:G46511PG-GLYCOSEQ00139359 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2052.67 has canonical residue n-glycan a-d-neupnac 16

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.